TECTONIC THERAPEUTIC, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
TECTONIC THERAPEUTIC, INC. (TECX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -2.20% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2025-03-20
- TECTONIC THERAPEUTIC, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was -2.20%.
- TECTONIC THERAPEUTIC, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was -4.40%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|
| 2024-12-31 | -2.20% 10-K · filed 2025-03-20 |
| 2023-12-31 | -4.40% 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |